A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes

Clinical trial NCT06871761 · COMPLETED

Trial details

NCT number: NCT06871761
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Adult Patients With Type 2 Diabetes

Start date: 2024-05-08
Primary completion: 2025-05-13
Enrollment: 393

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.